Lantheus Holdings Inc

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

LNTH

Financials

Lantheus Holdings Inc

Notizie

Citizens conferma il rating su Lantheus dopo l’estensione della revisione FDA

Lantheus mantiene rating Outperform da William Blair dopo rinvio FDA

FDA estende la revisione del farmaco per tumori neuroendocrini di Lantheus

Jefferies alza il target su Lantheus per le prospettive PSMA PET

Azioni Wall Street oggi: 5 titoli da monitorare nell'apertura shock

Citizens conferma il rating su Lantheus per opportunità di royalty

Citizens reiterates Lantheus stock rating on royalty opportunities

La FDA approva PYLARIFY TruVu di Lantheus per imaging del cancro alla prostata

FDA approves Lantheus’ PYLARIFY TruVu for prostate cancer imaging

Lantheus riceve approvazione provvisoria FDA per farmaco oncologico generico

Lantheus receives FDA tentative approval for generic cancer drug

Truist alza il target sul titolo Lantheus per le prospettive di crescita